Community Research and Development Information Service - CORDIS

Results 1 - 10 of 95
Order by: Results/page:
12 3 4 5 6 7 8 9 10 > 
European Gram Negative Antibacterial Engine
ID: 115583
Start date: 2014-02-01, End date: 2020-01-31
The intensive use and misuse of antibiotics has resulted in some level of antibiotic resistance in essentially all human bacterial pathogens. There is a growing concern that the loss of therapeutic options will present us with a post-antibiotic era where present and future me...
Programme: FP7-JTI
Record Number: 203716
Last updated on: 2017-04-24
European Bank for induced pluripotent Stem Cells
ID: 115582
Start date: 2014-01-01, End date: 2017-12-31
EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to est...
Programme: FP7-JTI
Record Number: 203673
Last updated on: 2017-04-24
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-04-17
Incorporating real-life clinical data into drug development
ID: 115546
Start date: 2013-10-01, End date: 2017-03-31
When a new medicine reaches the market, it is accompanied by an extensive data package that provides information about the safety and efficacy of the medicine in a clinical trial setting. However, assessing the expected future value of the medicines when used in “real world” ...
Programme: FP7-JTI
Record Number: 203672
Last updated on: 2017-04-17
European Lead Factory
[PROJECT] EUC²LID - European Lead Factory
ID: 115489
Start date: 2013-01-01, End date: 2017-12-31
The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental valida...
Programme: FP7-JTI
Record Number: 203710
Last updated on: 2017-04-17
Delivering  European Translational Information & Knowledge Management Services
ID: 115446
Start date: 2012-10-01, End date: 2017-09-30
Since its inception the IMI has funded over 30 public-private partnership projects. Many of these projects are centered upon data intensive translational research and are employing integrative analysis approaches to achieve their goals. Although a common KM platform for IMI p...
Programme: FP7-JTI
Record Number: 203709
Last updated on: 2017-04-17
Oral biopharmaceutics tools
[PROJECT] ORBITO - Oral biopharmaceutics tools
ID: 115369
Start date: 2012-10-01, End date: 2017-09-30
The OrBiTo project will deliver novel methods and a framework for rational application of predictive biopharmaceutics tools for oral drug delivery. This will be achieved through novel propsective studies to define new methodlogies which will be validated using historical data...
Programme: FP7-JTI
Record Number: 203706
Last updated on: 2017-04-17
European Patients' Academy on Therapeutic Innovation
ID: 115334
Start date: 2012-02-01, End date: 2017-01-31
"The proposed project ""European Patients' Academy on Therapeutic Innovation"" (EUPATI) contributes to IMI’s goal of raising patients’ awareness and participation in pharmaceutical R&D. This patient-led academy will provide scientifically reliable, objective, comprehensive in...
Programme: FP7-JTI
Record Number: 203729
Last updated on: 2017-04-17
DIabetes REsearCh on patient sTratification
ID: 115317
Start date: 2012-02-01, End date: 2019-01-31
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of t...
Programme: FP7-JTI
Record Number: 203699
Last updated on: 2017-04-17
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
ID: 115303
Start date: 2012-03-01, End date: 2017-11-30
The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia...
Programme: FP7-JTI
Record Number: 203697
Last updated on: 2017-04-17
12 3 4 5 6 7 8 9 10 > 
List retrieved on: 2017-04-28
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top